Status:
COMPLETED
Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)
Lead Sponsor:
AstraZeneca
Conditions:
Perennial Allergic Rhinitis
Allergic Rhinitis
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergi...
Eligibility Criteria
Inclusion
- Main
- General good health, other than perennial allergic rhinitis
- History and diagnosis of perennial allergic rhinitis by skin prick test
- Main
Exclusion
- Participation in any investigational drug trial within the 30 days preceding the Screening Visit
- A known hypersensitivity to any corticosteroid or any of the excipients in the formulation
- Use of any prohibited concomitant medications as defined by the study protocol
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
April 1 2005
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00163501
Start Date
December 1 2003
End Date
April 1 2005
Last Update
November 30 2016
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Altana Pharma/Nycomed
Encinitas, California, United States, 92024
2
Altana Pharma/Nycomed
Huntington Beach, California, United States, 92647
3
Altana Pharma/Nycomed
Long Beach, California, United States, 90806
4
Altana Pharma/Nycomed
Los Angeles, California, United States, 90025